MEENA BANSAL MD
Prescription History 1962432476
Internal Medicine - Hepatology in New York, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MEENA BANSAL MD, an active Hepatology specialist practicing in New York, NY. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 150 documented patient claims. Among these therapy options, the most frequently utilized medication is Ursodiol, which accounts for 49 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| Ursodiol | 49 | $125.25▼ below NY avg | ▲ More than typical |
About Ursodiol: Ursodiol is used to dissolve certain types of gallstones, to prevent gallstones from forming in obese patients who are losing weight rapidly, and to treat a certain type of liver disease (primary biliary cholangitis). Show more ▾ Ursodiol is a bile acid. An epimer of chenodeoxycholic acid. It is a mammalian bile acid found first in the bear and is apparently either a precursor or a product of chenodeoxycholate. Its administration changes the composition of bile and may dissolve gallstones. It is used as a cholagogue and choleretic. In 2024, this provider wrote 49 Medicare prescriptions for Ursodiol, about 1.6 times the volume of the typical New York prescriber of this medication (30.1). Medicare paid an average of $125.25 per fill, versus $160.52 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 59 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Carvedilol | 23 | $6.44▼ below NY avg | ▼ Less than typical |
About Carvedilol: Carvedilol is used to treat high blood pressure and heart failure. Show more ▾ It is also used after a heart attack to improve the chance of survival if your heart is not pumping well. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural substances in your body, such as epinephrine, on the heart and blood vessels. This effect lowers your heart rate, blood pressure, and strain on your heart. Carvedilol belongs to a class of drugs known as alpha and beta blockers. A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION. In 2024, this provider wrote 23 Medicare prescriptions for Carvedilol, about half the volume of the typical New York prescriber of this medication (54.3). Medicare paid an average of $6.44 per fill, versus $8.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 33.5 30-Day Fills standardized to 30-day supplies 1,005 Days of Medication total across all patients in 2024 | |||
| Lactulose | 19 | $24.85▼ below NY avg | ▼ Less than typical |
About Lactulose: This medication is a laxative used to treat constipation. Show more ▾ It may help to increase the number of bowel movements per day and the number of days you have a bowel movement. Lactulose is a colonic acidifier that works by increasing stool water content and softening the stool. It is a man-made sugar solution. A synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It has also been used in the diagnosis of gastrointestinal disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p887) In 2024, this provider wrote 19 Medicare prescriptions for Lactulose, about half the volume of the typical New York prescriber of this medication (35.6). Medicare paid an average of $24.85 per fill, versus $154.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 19.3 30-Day Fills standardized to 30-day supplies 503 Days of Medication total across all patients in 2024 | |||
| EpclusaSofosbuvir/Velpatasvir | 17 | $22,966.60▼ below NY avg | ≈ Typical |
About Epclusa: This medication is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Show more ▾ It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer. It is not known if this treatment can prevent you from passing the virus to others. Do not share needles, and practice "safer sex" (including the use of latex condoms) to lower the risk of passing the virus to others. A combined pharmaceutical preparation of the antiviral agents sofosbuvir and valpatasvir that is used to treat all six major genotypes of HEPATITIS C VIRUS (HCV) infections. In 2024, this provider wrote 17 Medicare prescriptions for Epclusa, about 86% of the volume of the typical New York prescriber of this medication (19.7). Medicare paid an average of $22,966.60 per fill, versus $23,608.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 17 30-Day Fills standardized to 30-day supplies 476 Days of Medication total across all patients in 2024 | |||
| Entecavir | 16 | $148.01▼ below NY avg | ▼ Less than typical |
About Entecavir: See also Warning section. Show more ▾ Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the hepatitis B virus. Long-term infection can cause liver damage, rarely liver cancer, and liver failure. Entecavir helps to decrease the amount of hepatitis B virus in your body. It is unknown if this medication lowers your chance of getting liver cancer or liver damage. Entecavir is an antiviral that belongs to a class of drugs known as hepatitis B virus nucleoside reverse transcriptase inhibitors. Entecavir is not a cure for hepatitis B. It does not prevent the spread of the virus to others through sexual contact or blood/body fluid contamination (such as sharing used needles). In 2024, this provider wrote 16 Medicare prescriptions for Entecavir, about 62% of the volume of the typical New York prescriber of this medication (25.9). Medicare paid an average of $148.01 per fill, versus $197.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 24 30-Day Fills standardized to 30-day supplies 720 Days of Medication total across all patients in 2024 | |||
| OcalivaObeticholic Acid | 14 | $14,905.32 | ≈ Typical |
About Ocaliva: This medication is used alone or in combination treatment for a certain liver disease (primary biliary cholangitis-PBC). Show more ▾ This disease slowly destroys the bile ducts in the liver. When bile ducts are damaged, harmful substances can build up in bile and scar the liver. Obeticholic acid works by causing your liver to make less bile, and by helping bile flow out of the liver. A farnesoid X receptor agonist and anticholestatic agent that is used in the treatment of chronic liver diseases. In 2024, this provider wrote 14 Medicare prescriptions for Ocaliva, about 81% of the volume of the typical New York prescriber of this medication (17.2). Medicare paid an average of $14,905.32 per fill, versus $10,497.31 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| XifaxanRifaximin | 12 | $3,028.66 | ▼ Less than typical |
About Xifaxan: This medication is used to treat diarrhea caused by the common bacteria known as E. Show more ▾ coli ("traveler's diarrhea"). Rifaximin should not be used if you have a fever or bloody diarrhea. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Rifaximin is also used to treat irritable bowel syndrome with diarrhea. It is also used to prevent a brain problem caused by liver disease (hepatic encephalopathy). A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY. In 2024, this provider wrote 12 Medicare prescriptions for Xifaxan, about half the volume of the typical New York prescriber of this medication (24.8). Medicare paid an average of $3,028.66 per fill, versus $2,761.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MEENA BANSAL MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hepatology prescribing approach at this New York, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NY prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
